लोड हो रहा है...

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence

Poor treatment adherence is problematic in many therapy areas, including multiple sclerosis (MS). Several immunomodulatory drugs are available for the treatment of MS, all of which require frequent parenteral administration. Current first-line therapies are two formulations of interferon (IFN) beta-...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Patti, Francesco
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2010
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819898/
https://ncbi.nlm.nih.gov/pubmed/20165593
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!